TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Kringle Pharma, Inc. ( (JP:4884) ).
Kringle Pharma, Inc. reported its financial results for the fiscal year ending September 30, 2025, showing a decline in net sales and increased losses compared to the previous year. The company’s financial position weakened with reduced total assets and net assets, impacting its equity ratio and cash flows, which may affect its operational strategies and stakeholder confidence.
More about Kringle Pharma, Inc.
Kringle Pharma, Inc. is a company listed on the Tokyo Stock Exchange, primarily operating in the pharmaceutical industry. The company focuses on developing innovative therapies and has a market focus on advancing healthcare solutions.
Average Trading Volume: 79,729
Technical Sentiment Signal: Sell
Current Market Cap: Yen3.07B
For an in-depth examination of 4884 stock, go to TipRanks’ Overview page.